Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sphere Fluidics

Sphere Fluidics
2010 FOUNDED
PRIVATE STATUS
31-40 EMPLOYEES
Later Stage VC LATEST DEAL TYPE
$4.82M LATEST DEAL AMOUNT
17 INVESTORS
Description

Developer of single cell analysis systems intended to find rare and valuable biological variants. The company's single cell analysis systems help to enable discovery of new cell strains and molecules for use in single cell analysis and characterization, enabling life science companies to single cell analysis systems.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Discovery Tools (Healthcare)
Primary Office
  • The Jonas Webb Building AND The Meditrina Building
  • Babraham Research Campus, Babraham
  • Cambridge CB22 3AT
  • England, United Kingdom

+44 01223 000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Sphere Fluidics’s full profile, request a free trial.

Sphere Fluidics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Later Stage VC 10-Jun-2019 $4.82M 000.00 Completed Generating Revenue
13. Debt - General 00.000 000.00 Completed Generating Revenue
12. Grant 17-Jul-2017 00.00 000.00 Completed Generating Revenue
11. Later Stage VC (Series B) 10-Feb-2016 000 000.00 Completed Generating Revenue
10. Grant 01-Jan-2016 00000 00.00 Completed Generating Revenue
9. Angel (individual) 00.000 00.00 Completed Generating Revenue
8. Grant 26-Mar-2015 00.00 00.000 Completed Generating Revenue
7. Early Stage VC 23-Feb-2015 00000 00.000 000.00 Completed Generating Revenue
6. Early Stage VC 01-Jan-2015 $471K $6.69M Completed Startup
5. Early Stage VC 24-Jun-2014 $2.29M $6.22M 000.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Sphere Fluidics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A1 0,000 00.000000 0000.00 0000.00 00 0000.00 000
Series A 0,000 00.000000 0000.00 0000.00 00 0000.00 00.00
Ordinary 4 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 3 000 00.000000 0000.00 0000.00 00 0000.00 0.000
Ordinary 2 2,031 $0.001531 $122.48 $122.48 1x $122.48 6.8%
Ordinary 1 1,563 $0.001531 $122.43 $122.43 1x $122.43 5.23%
To view this company’s complete Cap Table, request access »

Sphere Fluidics Competitors (40)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genomic Expression Venture Capital-Backed New York, NY 0 00000 0000000000 00000
000 000000000 0000 Formerly VC-backed Tucson, AZ 000 00000 00000000000 00000
00000000 000-00000 Corporate Backed or Acquired Fremont, CA 00 000.00 000000&0 000.00
00000000000 Private Equity-Backed San Diego, CA 0000 000000000000
000000000 00000000 Formerly VC-backed Billerica, MA 00 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Sphere Fluidics Investors (17)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Oxford Investment Consultants Other Minority 000 0000 000000 0
Eurostars Government 000 0000 000000 0
Greenwood Way Capital Angel Group Minority 000 0000 000000 0
Centre for Process Innovation Not-For-Profit Venture Capital 000 0000 000000 0
Amadeus Capital Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 17 investors. Get the full list »

Sphere Fluidics Executive Team (9)

Name Title Board
Seat
Contact
Info
Frank Craig Ph.D Chief Executive Officer & Board Member
Rob Treanor Director of Operations
Andrew Campbell Finance Director
Marian Rehak Vice President, Research & Development
Robert Marchmont Vice President, Sales & Marketing

1 Former Executive

You’re viewing 5 of 9 executives. Get the full list »

Sphere Fluidics Board Members (6)

Name Representing Role Since Contact
Info
Andrew Mackintosh Ph.D The Royal Society of London Chairman 000 0000
Chris Abell Ph.D Self Co-Founder & Chairman of Scientific Advisory Board 000 0000
Frank Craig Ph.D Sphere Fluidics Chief Executive Officer & Board Member 000 0000
Ian Gray 24Haymarket Board Member 000 0000
Yuichiro Morimoto Self Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 6 board members. Get the full list »